Abstract

The invention proposes a new approach to rare genetic diseases for which no cures are available, only symptomatic treatments through the preparation of novel multivalent molecules active toward the human enzymes responsible for them

Research Institution

Università degli Studi di Firenze

Numero di pubblicazione

WO2017137895A1

TRL

3

Technologies, Systems, Applications

Biotechnologies, New drugs development